病理
融合基因
生物
子宫内膜间质肉瘤
原位杂交
癌症研究
分子细胞遗传学
免疫组织化学
间质细胞
医学
荧光原位杂交
分子生物学
肉瘤
遗传学
免疫学
染色体
基因
信使核糖核酸
作者
Zehra Ordulu,Stefanie Avril,Valentina Nardi,Dora Dias‐Santagata,Esther Oliva
出处
期刊:International Journal of Gynecological Pathology
[Ovid Technologies (Wolters Kluwer)]
日期:2021-06-02
卷期号:41 (3): 244-250
被引量:2
标识
DOI:10.1097/pgp.0000000000000795
摘要
The molecular knowledge of endometrial stromal neoplasms has been rapidly increasing and is considered complementary to morphologic and immunohistochemical findings for better categorization of these tumors. The most common molecular alteration observed in low-grade endometrial stromal sarcomas is the JAZF1-SUZ12 fusion, whereas, low-grade endometrial stromal sarcoma with sex cord-like differentiation have been shown more commonly to have fusions involving PHF1. Herein, we present a low-grade endometrial stromal sarcoma with sex cord-like differentiation with a fluorescence in situ hybridization showing the apparent loss of one copy of JAZF1 5' and 3' signals, rather than the expected "break-apart" pattern seen in the setting of a JAZF1 fusion. The case was then further evaluated by chromosome microarray and RNA fusion analysis. Overall, the molecular findings supported a PHF1-JAZF1 fusion with deletions right before and after the JAZF1 locus, impairing probe binding and resulting in the unusual "deletion" pattern observed in the JAZF1 fluorescence in situ hybridization, which would not intuitively suggest a fusion involving JAZF1. This case illustrates the importance of integration of morphological and molecular findings as well as the limitations of fluorescence in situ hybridization in detecting fusions, particularly in the setting of more complex chromosomal alterations even though the fusion partners are well-known.
科研通智能强力驱动
Strongly Powered by AbleSci AI